Male Infertility and IVF: Complete Guide to ICSI and TESE for Oligospermia, Asthenospermia, and Azoospermia
Comprehensive guide to IVF treatment for male factor infertility: ICSI single sperm injection for oligospermia and asthenospermia, TESE/TESA surgical sperm retrieval for azoospermia, success rates, and treatment protocols.
Male Infertility and IVF: Complete Guide to ICSI and TESE for Oligospermia, Asthenospermia, and Azoospermia
Key Takeaways: Male factor infertility accounts for approximately 40-50% of all infertility cases — but it does not mean parenthood is impossible. AddBaby Medical & Fertility Center uses ICSI (intracytoplasmic sperm injection) and TESE/TESA (surgical sperm retrieval) to help men with severe oligospermia, asthenospermia, and even azoospermia achieve biological fatherhood. This guide covers diagnosis, treatment protocols, success rates, and costs.
Quick Reference Summary
| Item | Details |
|---|---|
| Who it's for | Men with oligospermia, asthenospermia, teratospermia, or azoospermia and their partners |
| Core technologies | ICSI single-sperm injection; TESE/TESA surgical sperm retrieval |
| ICSI additional cost | ~$1,500-2,500 USD above standard IVF |
| TESE procedure cost | Obstructive: ~$750-1,500 USD; Micro-TESE: ~$2,200-4,500 USD |
| Success rate reference | ICSI fertilization rate 70-80%; TESE sperm retrieval 50-95% |
Classification and WHO Diagnostic Criteria for Male Infertility
Based on the World Health Organization's 2021 semen analysis reference values, male infertility is classified into several main categories:
Semen Parameter Abnormality Classifications
Oligospermia (Low Sperm Count)
- Mild oligospermia: sperm concentration 5-16 x 10⁶/mL
- Moderate oligospermia: 1-5 x 10⁶/mL
- Severe oligospermia: <1 x 10⁶/mL
- Cryptozoospermia: only rare sperm found after centrifugation
Asthenospermia (Poor Sperm Motility)
- WHO criterion: Progressive motility (PR grade) <42%
- Or total motility (PR+NP) <50%
Teratospermia (Abnormal Sperm Morphology)
- WHO criterion: Normal morphology <4% (Kruger strict criteria)
- Common abnormalities: head defects (macrocephaly, microcephaly, duplicated head), neck/midpiece defects, tail defects
Azoospermia (No Sperm)
- Obstructive Azoospermia (OA): testicles produce sperm normally, but the ductal system is blocked
- Common causes: vasectomy, congenital bilateral absence of vas deferens (CBAVD), post-infectious epididymal obstruction
- Non-Obstructive Azoospermia (NOA): impaired testicular spermatogenesis — sperm production is reduced or absent
- Common causes: Klinefelter syndrome (47,XXY), Y chromosome microdeletions, cryptorchidism, mumps orchitis
Sperm DNA Fragmentation Index (DFI)
The DNA fragmentation index is a critically important but frequently overlooked test:
- Normal: DFI ≤15%
- Mildly elevated: 15-25% (may impair embryo development)
- Moderately elevated: 25-40% (significantly reduces implantation and live birth rates)
- Severely elevated: >40% (donor sperm should be considered)
High DFI is closely associated with recurrent implantation failure and recurrent miscarriage. All male infertility patients are strongly advised to undergo DFI testing.
ICSI: Intracytoplasmic Sperm Injection — In Depth
What Is ICSI?
ICSI (Intracytoplasmic Sperm Injection) is a micromanipulation procedure in which an embryologist uses an ultra-fine glass needle (inner diameter ~5-7 micrometers) under high-powered microscopy to select a single morphologically normal, motile sperm and directly inject it into the cytoplasm of a mature egg.
Unlike conventional IVF — where large numbers of sperm are co-incubated with eggs and fertilization relies on natural sperm penetration — ICSI bypasses the natural penetration step entirely, requiring only a single viable sperm per egg.
When ICSI Is Indicated
ICSI is the preferred or recommended approach in the following situations:
- Moderate-to-severe oligospermia (sperm concentration <5 x 10⁶/mL)
- Severe asthenospermia (progressive motility <20%)
- Severe teratospermia (normal morphology <1%)
- After TESA/TESE surgical sperm retrieval (obstructive or non-obstructive azoospermia)
- Previous conventional IVF with poor or total fertilization failure
- Use of cryopreserved-thawed sperm
- Elevated sperm DNA fragmentation (DFI >25%)
- Recurrent IVF implantation failures
ICSI Fertilization and Success Rates
| Outcome Metric | Data Range |
|---|---|
| Normal fertilization rate (2PN) | 70-80% |
| Good-quality embryo rate | 50-65% |
| Blastocyst development rate | 40-55% |
| Clinical pregnancy rate (under 35) | 50-65% per transfer cycle |
| Live birth rate (under 35) | 40-55% per transfer cycle |
ICSI Costs
At AddBaby's partner centers in Thailand, ICSI adds approximately $1,500-2,500 USD to the cost of a standard IVF cycle. In many Thailand premium reproductive centers, ICSI has become standard practice and is often included within the baseline IVF package.
For full IVF-ICSI package pricing details, visit AddBaby's service page.
TESE/TESA Surgical Sperm Retrieval: Treatment for Azoospermia
Sperm Retrieval for Obstructive Azoospermia (OA)
When azoospermia is caused by ductal blockage (OA), sperm production in the testes is typically normal, and retrieval is relatively straightforward:
TESA (Testicular Sperm Aspiration)
- Procedure: Fine needle inserted into the testis under local anesthesia to aspirate sperm
- Best for: Obstructive azoospermia — first-line approach
- Invasiveness: Minimal (comparable to a blood draw)
- Sperm retrieval success rate: Over 95% for obstructive azoospermia
- Yield: Typically sufficient for same-cycle IVF-ICSI use
PESA (Percutaneous Epididymal Sperm Aspiration)
- Procedure: Aspiration from the epididymis (the sperm storage organ adjacent to the testis)
- Best for: Epididymal obstruction causing azoospermia
- Advantage: Sperm motility is often superior to TESA-retrieved sperm
Microsurgical TESE (Micro-TESE)
- Procedure: Testis opened under operating microscope; seminiferous tubules are microscopically examined to identify focal spermatogenesis regions
- Best for: Salvage when conventional TESA/PESA fails in OA patients
- Invasiveness: More significant — requires general anesthesia
- Recovery: Approximately 1-2 weeks
Sperm Retrieval for Non-Obstructive Azoospermia (NOA)
NOA is the more challenging scenario. Testicular spermatogenesis itself is impaired, but some NOA patients retain isolated focal areas of sperm production (focal spermatogenesis) that can be identified microscopically.
Micro-TESE is the standard treatment for NOA
| Underlying Cause | Micro-TESE Success Rate |
|---|---|
| Klinefelter syndrome (47,XXY) | 40-60% |
| Y chromosome AZFc microdeletion | 50-70% |
| Y chromosome AZFa/b complete deletion | Very low (<5%) — surgery usually not recommended |
| Post-cryptorchidism (orchidopexy) | 40-60% |
| Idiopathic NOA | 40-55% |
| Post-mumps orchitis | 30-50% |
Critical note: Y chromosome microdeletion testing is mandatory before Micro-TESE. Men with complete AZFa or AZFb deletions have sperm retrieval rates below 5%, and this must be communicated clearly before surgery is considered.
Coordinating TESE with IVF Timing
The timing coordination between male sperm retrieval and female egg retrieval is critical:
Option 1: Fresh TESE Synchronized with Egg Retrieval
- Both procedures performed on the same day
- Advantage: Fresh sperm with optimal motility
- Risk: If sperm retrieval fails, the entire cycle may be compromised (backup frozen sperm reduces this risk)
Option 2: Freeze-First Strategy (Recommended for NOA)
- TESE performed and sperm cryopreserved in advance
- Female IVF cycle proceeds using thawed sperm
- Advantage: Eliminates catastrophic cycle failure if retrieval is challenging
- AddBaby recommendation: This is the preferred approach for all NOA patients
Sperm DNA Fragmentation and Treatment Decision-Making
High DFI (sperm DNA fragmentation) is an important factor affecting IVF outcomes that is frequently undertreated:
Clinical Significance of DFI Testing
| DFI Level | Impact on IVF | Recommendation |
|---|---|---|
| <15% | No significant impact | Standard protocol |
| 15-25% | Mild impact on embryo development | Consider ICSI |
| 25-40% | Significant impact on implantation and live birth rates | ICSI + epididymal/testicular sperm |
| >40% | Severe impact, high miscarriage rate | Consider donor sperm or comprehensive evaluation |
Interventions to Reduce DFI
Before surgical sperm retrieval, the following may effectively reduce sperm DNA damage:
- Antioxidant therapy: Vitamin C, Vitamin E, Coenzyme Q10, zinc, folate (3-6 months of treatment)
- Optimal abstinence interval: 48-72 hours (excessively long abstinence paradoxically increases DFI)
- Lifestyle modification: Quit smoking, limit alcohol, avoid high-temperature environments (sauna, hot baths)
- Epididymal/testicular sperm: DNA fragmentation in epididymal and testicular sperm is typically significantly lower than in ejaculated sperm
When Is Donor Sperm Recommended?
While the majority of male infertility patients can achieve biological parenthood through ICSI and TESE, the following situations may warrant considering donor sperm options:
- Complete failure of NOA Micro-TESE (no sperm found across multiple surgical attempts)
- Complete Y chromosome AZFa or AZFb deletion (retrieval success rate <5%)
- DFI >40% with no response to conservative treatment
- Severe hereditary genetic diseases (near-100% transmission probability to offspring)
- Male partner's refusal of surgery or medical contraindications
Choosing donor sperm is a significant decision involving emotional and ethical dimensions. AddBaby's fertility counselors provide comprehensive psychological support to help couples make the choice that is right for them, accompanying them through every step of the decision and treatment process.
Complete Treatment Pathway
Step 1: Comprehensive Male Infertility Workup
- Semen analysis (at least 2 tests, 1 month apart)
- Sperm DNA fragmentation index (DFI) testing
- Reproductive hormone panel (FSH, LH, testosterone, prolactin, estradiol, AMH)
- Karyotype analysis (46,XY or abnormal)
- Y chromosome microdeletion testing (mandatory for azoospermia)
- Reproductive tract ultrasound (testes, epididymis, prostate)
Step 2: Treatment Protocol Determination
Based on evaluation results, the reproductive specialist tailors a personalized protocol:
- Mild oligospermia/asthenospermia → Conventional IVF or ICSI
- Moderate-to-severe oligospermia/asthenospermia → ICSI
- Obstructive azoospermia → TESA/PESA + ICSI
- Non-obstructive azoospermia → Micro-TESE + ICSI, or donor sperm consideration
Step 3: Coordination of Female Stimulation and Male Retrieval
- Synchronized (fresh protocol) or separate (freeze-first protocol)
Step 4: Laboratory Operations
- ICSI fertilization: embryologist performs single-sperm injection
- Embryo culture: in vitro development to Day 3 (cleavage stage) or Day 5-6 (blastocyst)
- Embryo biopsy: if PGT-A/PGD genetic testing is indicated, performed at this stage
Step 5: Embryo Transfer
- Fresh or frozen embryo transfer (FET)
- Serum hCG blood test 14 days post-transfer to confirm pregnancy
For detailed information on the complete IVF process, visit AddBaby's IVF-ICSI service page, or contact our male infertility specialists directly for professional consultation.
Frequently Asked Questions
Q1: Does ICSI have a higher success rate than conventional IVF?
A: This is a common misconception. ICSI's advantage over conventional IVF applies specifically to the fertilization rate — by physically injecting sperm, ICSI bypasses the natural penetration step, producing significantly higher fertilization rates when sperm quality is poor. However, once fertilization is achieved, embryo development rates, implantation rates, and clinical pregnancy rates are comparable between ICSI and conventional IVF. For couples with normal semen parameters, ultimate live birth rates are similar between the two approaches. ICSI is primarily a tool to overcome fertilization barriers — not a universal method to boost overall IVF success rates.
Q2: Will poor sperm quality be inherited by the child?
A: In some cases, yes — it depends on the underlying cause of infertility. Key scenarios: (1) Chromosomal abnormalities (e.g., Klinefelter syndrome 47,XXY): sons have a meaningful probability of inheritance; (2) Y chromosome microdeletions: sons born via ICSI will almost certainly inherit the father's Y chromosome deletion and may face infertility themselves; (3) CBAVD (congenital bilateral absence of vas deferens): typically associated with CFTR gene mutations with hereditary implications; (4) Functional causes (varicocele, infection, lifestyle): these do not carry genetic hereditary risk to offspring. For cases with suspected genetic etiology, AddBaby recommends PGT-A/PGD genetic testing (preimplantation genetic testing) to screen for chromosomally normal embryos before transfer, preventing transmission of genetic conditions. Learn more at AddBaby's IVF-PGD genetic screening service.
Q3: Does azoospermia always mean needing donor sperm?
A: Absolutely not. Approximately 50-95% of azoospermic men (depending on the underlying cause) can have sperm successfully retrieved through TESA or Micro-TESE to achieve biological parenthood. Obstructive azoospermia has particularly high retrieval success (>95%). Non-obstructive azoospermia has lower success rates (40-70%), but still provides a meaningful proportion of patients with viable sperm. Before deciding to forgo biological parenthood through donor sperm, a comprehensive evaluation is strongly recommended — including at least one Micro-TESE attempt at an experienced reproductive center. AddBaby's Thailand partner centers have extensive NOA Micro-TESE expertise. Reach out to us to discuss your specific situation.
Q4: Does TESE surgery affect testicular function?
A: Technically, any testicular surgery carries some potential for localized tissue effects, but a properly performed TESA (fine-needle aspiration) has minimal impact on testicular function. Micro-TESE, due to its greater surgical scope, carries a small risk of modest testosterone level decline, but most patients recover within 6-12 months. Compared with the potential reproductive benefit, this risk is generally acceptable. Choosing an experienced urologist/reproductive surgeon and following rigorous surgical protocols minimizes these risks significantly.
Conclusion
Male infertility does not equal inability to father children. Modern assisted reproductive technology — particularly the combination of ICSI and TESE — has opened a path to parenthood for the vast majority of men with fertility challenges:
- Oligospermia / asthenospermia / teratospermia → ICSI is the standard approach, with 70-80% fertilization rates
- Obstructive azoospermia → TESA sperm retrieval success >95%, combined with ICSI for parenthood
- Non-obstructive azoospermia → Micro-TESE gives 40-70% of patients a viable opportunity
- High DFI → Epididymal/testicular sperm + ICSI + PGT-A when indicated
AddBaby Medical & Fertility Center's team of experienced andrologists and reproductive specialists in Thailand provides comprehensive solutions from semen analysis to embryo transfer. If you or your partner are dealing with male infertility, we welcome you to contact our fertility consultants for a personalized professional assessment and individualized treatment plan. You can also explore our fertility guarantee programs to proceed through every step of treatment with confidence.
This article has been reviewed by the AddBaby Medical & Fertility Center medical team. Content is for informational purposes only and does not constitute medical advice. Please consult a qualified medical professional for fertility-related concerns. Last updated: February 2026